Investigation of mutant hepatitis B virus in core antibody seropositive cases of blood donor population

Journal of Medical Sciences

Volumn 8, Issue 3, 2008, Pages 316-320

  Arabaci, Filiz ^a   Oldacay, Mehmet ^a  

^a Canakkale State Hospital   (Turkey)

Author keywords

Blood transfusion; Isolated core positivity; Mutant HBV; Pooled sera PCR

Indexed keywords

HEPATITIS B CORE ANTIBODY;

ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; SEROLOGY; SEROPREVALENCE; VIRUS MUTATION;

EID: 73449099639     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2008.316.320     Document Type: Article

References (33)

1. Alhababi, F., TA. Sallam and C.Y. Tong, 2003. The significance of 'anti-HBc only' in the clinical virology laboratory. J. Clin. Virol., 27 (2): 162-169.
2. Balik, I., 1994. Chapter 2: Hepatitis B Epidemiology (Turkish). In: Viral Hepatit 94, Kilicturgay, K. (Ed.). 1st Edn. Viral Hepatitle Savasim Dernegi, Istanbul, pp: 8-12.
3. Bhatti, F.A., Z. Ullah, N. Salamat, M. Ayub and E. Ghani, 2007. Anti-hepatitis B core antigen testing, viral markers and occult hepatitis B virus infection in Pakistani blood donors: Implications for transfusion practice. Transfusion, 47 (1): 74-79.
4. Carman, W.F. and L.T. Mimms, 1997. Pre-S/S Gene Variants of Hepatitis B Virus. In: Viral Hepatitis and Liver Disease, Rizetto, M., R.H. Purcell, J.L. Gerin and G. Verne (Eds.). Minerva Medica, Turin, Italy, pp: 108-115.
5. Chevrier, M.C., M. St-Louis, J. Perreault, B. Caron, C. Castilloux, J. Laroche and G. Delage, 2007. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay. Transfusion, 47 (10): 1794-1802.
6. Dodd, R.Y., E.P. Notari and S.L. Stramer, 2002. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion, 42 (8): 975-979.
7. Eiras, A., S. Sauleda, D. Planelles, M. Sedeño, A. Ibarra, M.A. Vesga, E. Franco, J.A. Montoro, J.M. Hernández and R.G. Villaescusa, 2003. HCV screening in blood donations using RT-PCR in mini-pool The experience in Spain after routine use for 2 years. Transfusion, 43 (6): 713-720.
8. Heper, Y., R. Mistik, C. Ozakin and O. Tore, 1999. The correlation between the serological markers of hepatitis B virus (HBV) and HBV DNA: Results of Bursa region. Viral Hepatit Derg, 5 (2): 137-139 (In Turkish).
9. Hoofnagle, J.H., 1990. Post-transfusion hepatitis B. Transfusion, 30: 383-386.
10. Hoofnagle, J.H. and A.M. Di Besceglie, 1991. Serological diagnosis of acute and chronic viral hepatitis. Semin Live Dis., 11 (2): 73-83.
11. Howard, C.R. and L.M.C. Allison, 1995. Hepatitis B surface antigen variation and protective immunity. Intervirology, 38 (1-2): 35-40.
12. Jilg, W., E. Sieger, R. Zachoval and H. Schatzl, 1995. Individuals with antibodies against hepatitis B core antigen is the only serological marker for hepatitis B infection: High percentage of carriers of hepatitis B and C virus. J. Hepatol., 23 (1): 14-20.
13. Jongerius, J.M., M. Wester, H.T.M. Cuypers, W.R. von Osterdorp, P.N. Lelie, C.L. van der Poel and E.C. van Leeuwen, 1998. New hepatitis B mutant virus form in a blood donor that is undetectable in several hepatitis B screening assays. Transfusion, 38 (1): 56-59.
14. Kleinman, S.H., D.M. Strong, G.G. Teigtmeier and P.V. Holland 2005. Hepatitis B virus (HBV) DNA Screening of blood donations in minipools with the COBAS AmpliScreen HBV tests. Transfusion, 45 (8): 1247-1257.
15. Kojima, M., M. Shinizu, T. Tsuchimochi and M. Koyasu et al., 1991. Post-transfusion fulminant hepatitis B associated with pre-core defective HBV mutants. Vox Sang, 60 (1): 34-39.
16. Kuhns, M.C. and M.P. Busch, 2006. New strategies for blood donor screening for hepatitis B virus: Nucleic acid testing versus immunoassay methods. Mol. Diag. Ther., 10 (2): 77-91.
17. Levicnic-Stezinar, S., 2004. Hepatitis B surface antigen escape mutant in a fist time blood donor potentially missed by aroutine screening assay. Clin. Lab., 50 (1-2): 49-51.
18. Matsumoto, C., K. Nishioka, T. Oguchi, S. Mitsunaga, N. Nojiri, K. Takdokoro and T. Juji, 1997. Detection and quantitation of HBV DNA by semi-nested PCR in donated blood: Comparison with HBV serological markers. J. Virol. Methods, 66 (1): 61-69.
19. O'Brein, S.F., M.A. Fearon, Q.L. Yi, W. Fan, V. Scalia, I.R. Muntz and E.C. Vamvakas, 2007. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: The Canadian Blood Services experience. Transfusion, 47 (10): 1809-1815.
20. Ozbilge, H., F. Zeyrek, A. Mizrakli and B. Tumkaya, 2005. DNA positivity in Hepatitis B virus and serological tests. Erciyes Med. J., 27 (1): 17-21 (In Turkish).
21. Roth, W.K., M. Weber, S. Buhr, C. Drosten, W. Weichert, W. Sireis, D. Hedges and E. Seifried, 2002a. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe. Transfusion, 42 (7): 862-868.
22. Roth, W.K., M. Weber, D. Petersen, C. Drosten, S. Buhr, W. Sireis, W. Weichert, D. Hedges and E. Seifried, 2002b. NAT for HBV and anti-HBc testing increase blood safety. Transfusion, 42 (7): 869-875.
23. Sahin, K., M. Tekerekoglu, M. Koroglu, R. Durmaz and H. Ozerol, 2001. Hepatitis B virus DNA in the serum of HbsAg positive patients. Viral Hepatit Derg., 7 (2): 305-307 (In Turkish).
24. Sakugawa, H., H. Nakasone, T. Nakayoshi, Y. Kawakami, T. Yamashiro, T. Maeshiro, F. Kinjo and A. Saito, 2001. Correlation between serum transaminase activity and virus load among patients wita chronic liver disease type B. Hepatol. Res., 21 (2): 159-168.
25. Smith, R.M. and G.Y. Wu, 2002. Molecular Virology of Hepatitis B and C. In: Chronic Viral Hepatitis, Diagnosis and Therapeutics, Koff, R.S. and G.Y. Wu (Eds.). Humana Pres, New Jersey, USA., pp: 1-25.
26. Sonsuz, A., H. Senturk, S. Ozdemir, S. Karakurt, P. Akin and M. Gurakar, 1992. Chronic Hepatitis cases with isolated hepatitis B core positivity. Turk. J. Gastroenterol., 3 (1): 19-21 (In Turkish).
27. Stolz, M., M. Gilgen and C. Niederhauser, 2003. Hepatitis C virus-polymerase chain reaction minipool testing: 3 years in the largest Swiss blood transfusion service. Vox Sang., 84 (2): 105-109.
28. Taylor, P., G. Pickard, A. Gammie and M. Atkins, 2004. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory. J. Clin. Virol., 30 (Suppl 1): 11-15.
29. Thoai, D.L., S.D. Annabelle, B. Sebastien and G. Sylvie et al., 2006. Sensitivities of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms. J. Clin. Microb., 44 (7): 2321-2326.
30. Tomono, T., H. Murokawa, K. Minegishi and R. Yamanaka et al., 2002. Status of NAT screening for HCV, HIV and HBV: Experience in Japan. Dev. Biol. (Basel), 108: 29-39.
31. Weber, B., W. Melchior, R. Gehrke, H.W. Doerr, A. Berger and H. Rabenau 2001. Hepatitis B virus markers in anti-HBc only positive individuals. J. Med. Virol., 64 (3): 312-319.
32. Weber, B., T. Dengler, A. Berger, H.W. Doerr and H. Rabenau 2003. Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: Immulite HBsAg and Immulite 2000 HBsAg. J. Clin. Microbiol., 41 (1): 135-143.
33. Yalcin, K., H. Degertekrn, F. Yildiz and Y. Celik, 2003. Markers of disease activity in chronic hepatitis B virus infection. Clin. Invest. Med., 26 (1): 27-34.